Brüggemann, Roger J. M.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 1,556

Tackling the emerging threat of antifungal resistance to human health

Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., et al. (2022) · Nature Reviews Microbiology

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 1,179

Diagnosing COVID-19-associated pulmonary aspergillosis

Verweij, P. E., Gangneux, J.-P., Bassetti, M., Brüggemann, R. J. M., Cornely, O. A., Koehler, P., Lass-Flörl, C., van de Veerdonk, F. L., Chakrabarti, A., & Hoenigl, M. (2020) · The Lancet Microbe

Antifungal resistance and susceptibilityCOVID-19 Clinical Research Studies

Cited by 181

Molecular Mechanisms of 5-Fluorocytosine Resistance in Yeasts and Filamentous Fungi

Delma, F. Z., Al-Hatmi, A. M. S., Brüggemann, R. J. M., Melchers, W. J. G., de Hoog, S., Verweij, P. E., & Buil, J. B. (2021) · Journal of Fungi

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 96

Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19

van de Veerdonk, F. L., Kouijzer, I. J. E., de Nooijer, A. H., van der Hoeven, H. G., Maas, C., Netea, M. G., & Brüggemann, R. J. M. (2020) · JAMA Network Open

COVID-19 Clinical Research StudiesCoagulation, Bradykinin, Polyphosphates, and Angioedema

Cited by 65